TBPH
#2529
Theravance Biopharma, Inc. - Ordinary Shares
17.0 5 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.06%
Monthly Change
+1.01%
6 month change
-8.73%
Year Change
+18.82%
Previous Close
17.0 4
Open
17.0 5
Low
17.0 5
High
17.0 5
Volume
49
Financials
- Market Capitalization 885.21 M
- Employee 90
- Founded 2013
- CEO N/A
- Website www.theravance.com
- Headquarter California, United States
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.08
Price to sales ratio
8.97
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2505 |  IVA Inventiva S.A. - American Depository Shares | 4.71 USD | -3.88% | +2.39% | +5.84% | -20.30% | 910.15 M USD | ||
| 2511 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.27 USD | -4.82% | -2.93% | -10.70% | +25.40% | 898.60 M USD | ||
| 2551 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 46.48 USD | -0.81% | +1.86% | +20.48% | +54.26% | 868.24 M USD | ||
| 2581 |  CLYM Climb Bio, Inc. - Common Stock | 14.57 USD | -3.25% | -11.59% | +17.31% | +166.36% | 836.85 M USD |
Frequently asked questions about Theravance Biopharma, Inc.
What is the Theravance Biopharma, Inc. stock price today?
The current price of Theravance Biopharma, Inc. (TBPH) is 17.05. Over the past 24 hours, the stock has changed by +0.06%. Follow the TBPH chart for real-time price dynamics.
What is the stock ticker of Theravance Biopharma, Inc.?
Theravance Biopharma, Inc. trades under the ticker TBPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Theravance Biopharma, Inc. stock going up?
TBPH has changed by +0.35% over the last week, +1.01% over the last month, and +18.82% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Theravance Biopharma, Inc.?
Theravance Biopharma, Inc. currently has a market capitalization of 885.21 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Theravance Biopharma, Inc. earnings last quarter?
Last quarter, Theravance Biopharma, Inc. reported earnings of -0.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Theravance Biopharma, Inc. revenue for the last quarter?
Theravance Biopharma, Inc. reported quarterly revenue of 20.73 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Theravance Biopharma, Inc. net income for the last quarter?
Theravance Biopharma, Inc. reported net income of -5.9 M for the last quarter. The previous quarter showed -4.93 M, which means net income changed by -19.56%.
How many employees does Theravance Biopharma, Inc. have?
As of the latest available data, Theravance Biopharma, Inc. has 90 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Theravance Biopharma, Inc. stock?
You can buy Theravance Biopharma, Inc. (TBPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Theravance Biopharma, Inc. stock?
Investing in Theravance Biopharma, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TBPH chart and related analysis on metatrader.com as part of your research.